Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark S. Cohen Insider Profile
4 Followers
Mark S. Cohen, Director at Akari Therapeutics, holds 1.06M shares in Akari Therapeutics (Ticker: AKTX). Most recently, Mark S. Cohen Bought $1,055,600 shares of Akari Therapeutics on Sep 22, 2015 for an estimated value of 190.01K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-65.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Mark S. Cohen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark S. Cohen
Mark S. Cohen's Trading History
List of latest transactions for each holding click on a transaction to see Mark S. Cohen's performance on stock
You May Also Like
Mark S. Cohen insider profile FAQ
What is the percentage of profitable transactions made by Mark S. Cohen?
The percentage of profitable transactions made by Mark S. Cohen is 0%.
What is the average return per transaction made by Mark S. Cohen?
The average return per transaction made by Mark S. Cohen is -65.90%.
What stocks does Mark S. Cohen hold?
Mark S. Cohen holds: AKTX stocks.
What was Mark S. Cohen’s latest transaction?
Mark S. Cohen latest transaction was an Informative Buy of $190.01K.
What was Mark S. Cohen's most profitable transaction?
Mark S. Cohen’s most profitable transaction was an Informative Buy of AKTX stock on September 22, 2015. The return on the trade was -63.50%.
What is Mark S. Cohen's role in Akari Therapeutics?
Mark S. Cohen's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.